Pinealon Peptide: Benefits, Dosage, Side Effects & Research

You may have heard Andrew Huberman mention a peptide called Pinealon on a recent podcast. The detail that made everyone’s ears perk up: he said it gave him around three hours of REM sleep a night. If you have ever strapped on a sleep tracker and watched your REM sit at a depressing 60 minutes, that number stops you cold.

There is helpful context too. In the same breath, Huberman noted the peptide has very little human data behind it, that he no longer takes it, and that he was sharing his own experience rather than handing out a protocol.

So which is it? A quietly remarkable brain peptide, or another biohacking compound coasting on one famous anecdote? The real answer sits in between, and it is more interesting than either extreme.

Pinealon comes out of a fascinating corner of science: the Russian peptide bioregulator tradition, decades of work on tiny peptides that may talk directly to your genes. The mechanism is genuinely unusual. The preclinical data on neuroprotection is real. And the human evidence is thin enough that you should walk in curious, not convinced.

This is the honest, fully-sourced breakdown: what Pinealon actually is, exactly what Huberman said, how it is proposed to work, what the research supports, the doses people discuss, the side effects, the legal picture, and where it stands against peptides like Semax and Epitalon.

Quick disclaimer before we go further: Pinealon is sold strictly for research purposes only and is not approved by the FDA or other major regulators for human use. Everything here is educational and is not medical advice.

What people are looking into Pinealon for:

• Deeper, more restorative sleep and more REM
• Memory, focus, and mental clarity
• Neuroprotection and healthy brain aging
• Defense against oxidative stress in neurons
• Recovery of cognition after stress or injury
• Gene-expression and longevity pathways

Each of those is something researchers are exploring or something people report. None of them is settled science. Keep that lens on as we go.

What Pinealon Actually Is

Pinealon is a synthetic tripeptide. Three amino acids, strung together in a specific order: glutamic acid, aspartic acid, and arginine. In the shorthand peptide nerds use, that is Glu-Asp-Arg, or simply EDR. So when you see “EDR peptide” online, that is the same thing as Pinealon.

The chemistry is small and tidy. Molecular formula C15H26N6O8, a molecular weight of about 418 g/mol, CAS number 175175-23-2. For a sense of scale, this is one of the shortest bioactive peptides people use, which turns out to matter a lot for how it supposedly works.

One spec worth getting right: the third amino acid is arginine, not glycine. You will occasionally see the sequence written as Glu-Asp-Gly, but that is just a typo. The correct sequence is Glu-Asp-Arg.

Pinealon belongs to a family the Russians call peptide bioregulators. The idea behind them is elegant. Every tissue in your body is thought to make its own short regulatory peptides that fine-tune gene activity in that tissue. As you age, that signaling drifts. Supply the matching short peptide, the theory goes, and you help nudge the tissue back toward how it ran when it was younger. Pinealon is the version aimed at the brain and nervous system, modeled on peptides found in cortical brain tissue (the same biology behind the Russian neuro drug Cortexin).

This whole field traces back to 1971, when researchers at a military medical academy in Leningrad began isolating tissue peptides they called cytomedins. The name most tied to the work is Vladimir Khavinson, who went on to found the St. Petersburg Institute of Bioregulation and Gerontology and spent decades publishing on these short peptides. Pinealon is one of the later, fully synthetic members of that lineage, alongside peptides like Epitalon and Cortagen.

Quick myth-buster while we are here: “Pinealon” and “Pinealon Khavinson peptide” are the same molecule. And the active compound is identical whether a product is sold as an injectable, a nasal spray, or a capsule. What differs between those formats is how much of it your body can actually use, which we will get to.

The Andrew Huberman Pinealon Story (What He Really Said)

This is the section that sent half the internet searching for Pinealon, so let’s get it exactly right instead of repeating a game of telephone.

Huberman has discussed Pinealon in two places worth trusting. The first is his own Huberman Lab podcast episode with peptide physician Dr. Craig Koniver, released in October 2024. The second is a 2026 interview he gave on the goop podcast, where he walked through some of his personal peptide experiments.

What he described: using injectable Pinealon, paired with glycine, and watching his REM sleep roughly double on his sleep tracker over a span of months. He called the results great. He even noticed the benefit carried over to nights he did not dose.

Now the context he attached, which is worth holding onto. He pointed out that Pinealon has very little human data. He said he had since stopped taking it. And he was blunt that this was his own personal use, not a protocol he was recommending to anyone. He and Koniver also speculated, openly, about why it might work, rather than claiming to know.

One more thing the anecdote is confounded by: glycine on its own can improve sleep, so you cannot cleanly credit the peptide. Add the novelty and placebo effects that come with any new compound, and a single person’s experience, even a smart person’s, stays firmly in the “interesting lead” column.

If the REM angle is what pulled you in, the real bottleneck is finding the stuff, since a lot of vendors do not even carry Pinealon. Everest Peptides stocks it third-party tested, and code BRAINFLOW takes 10% off.

Pinealon vs Epitalon: Stop Confusing Them

If you spend ten minutes in peptide forums, you will see Pinealon and Epitalon used almost interchangeably. They are not the same, and the mix-up muddies everything from dosing to expected effects.

Pinealon is a tripeptide, Glu-Asp-Arg (EDR). Epitalon is a tetrapeptide, Ala-Glu-Asp-Gly (AEDG). Different length, different sequence, different research story. Epitalon is the one most associated with telomerase, melatonin, and circadian rhythm. Pinealon is the one centered on neuronal protection and gene expression in brain cells.

They come from the same Khavinson stable, which is exactly why people blur them. But if you read a claim about Pinealon “boosting melatonin” or “extending telomeres,” there is a good chance it actually belongs to Epitalon and got pasted onto the wrong peptide. Worth keeping straight. If you want the other side of the family, our Epitalon guide covers it in full.

How Pinealon Is Supposed to Work

Here is where Pinealon gets weird in a good way.

Most peptides work by landing on a receptor on the outside of a cell, like a key in a lock. Khavinson’s group proposes something far more unusual for these ultrashort peptides: that they are small enough to slip inside the cell, enter the nucleus, and interact directly with DNA and the proteins packaging it. In that model, Pinealon does not just knock on the door. It walks into the control room and helps decide which genes get switched on.

Is there support for that? Partially, and it is worth being precise about how much. Researchers have shown that short fluorescence-tagged peptides like these can penetrate into the nucleus of cells and interact with DNA in vitro. That is a real, peer-reviewed finding. It is also a finding in cells in a dish, not proof of gene regulation in a living human brain.

The most solid, repeatable effects are simpler than the gene-expression story. In a frequently cited 2011 study, Pinealon reduced free-radical levels and improved neuron survival in brain cell cultures, in a dose-dependent way, while nudging key signaling pathways. Translation: it acts as an antioxidant and helps stressed neurons stay alive. Those are the claims standing on the firmest ground.

From there the mechanism branches into protecting against apoptosis (programmed cell death), supporting synaptic connections, and possibly aiding circadian signaling. A 2021 review in the journal Molecules lays out the proposed gene-expression mechanism in the context of Alzheimer’s research, and it is a good read if you want the deep version. Just note the framing: it is a mechanistic hypothesis with cell and animal support, not a wrapped-up human case.

Two practical mechanism notes. Pinealon appears to cross the blood-brain barrier in animal studies, which is part of why the brain angle is plausible. And the survival of an oral tripeptide through stomach acid is debated, which is why injectable and intranasal forms get more attention from serious users than capsules do.

Pinealon Benefits: What the Evidence Actually Supports

Let me grade the benefits honestly instead of flattening them into a shrug. Some have real preclinical muscle. Some are pure anecdote with a good story attached. Both are worth knowing, as long as you can tell them apart.

The pattern is easy to read once it is laid out. The neuroprotection and antioxidant story is the strongest leg Pinealon stands on, backed by repeatable lab work. Some of it is striking, like the study where the peptide restored lost connections between neurons in an Alzheimer’s cell model, and follow-up work in a mouse model of the disease. The sleep story, the one Huberman made famous, is intriguing anecdote with a plausible mechanism but no controlled trial. The longevity and mood angles are more speculative for now, so keep your expectations there a little lighter while the science catches up.

A reasonable person can conclude this: Pinealon is a promising neuroprotective peptide with an interesting sleep signal, sitting on a preclinical foundation that has not yet been tested the way a drug would be. That is a real position. It is just not the same as “it works.”

What the Human Research Really Shows

Here is where the human side of Pinealon stands today.

The single most cited human result is a Russian report on 72 patients recovering from traumatic brain injury. Added to standard care, oral Pinealon was associated with improved memory, fewer and less intense headaches, and better emotional balance. That sounds great, and it is the kind of result that fuels the whole category. It is also observational, published in Russian, and run by the same lineage that developed the peptide.

Beyond that, the human research is still thin. There are no completed randomized controlled trials of Pinealon registered on ClinicalTrials.gov or the WHO trial registry. The animal work is more developed, including a rat study where Pinealon protected the offspring of stressed mothers and improved their learning, plus a small pilot in aged monkeys. Solid signals, all preclinical.

It is worth respecting where this research comes from. This is a serious, decades-long scientific program, and a good amount of it is published in respected English-language journals. The main caveat is simply that most of the work traces to one research group, and the studies tend to be small and early-stage. That does not make the findings wrong. It means independent labs still have room to confirm and build on them.

None of this dampens the promise. It just means the evidence is encouraging but still early, with broader independent confirmation as the natural next step. Plenty of compounds people rely on today started in exactly this spot.

Pinealon Dosage and Common Protocols

People search for Pinealon dosage because the real-world conversation has outrun the research, so it is worth laying out what shows up in studies, clinics, and user reports, with the source and quality attached to each.

If you want the quick version of what people usually do: most reach for the intranasal or injectable form over capsules, run it in short bursts of roughly 10 to 20 days, take a few weeks to a couple of months off between courses, and repeat only a handful of times a year rather than dosing daily forever. Sleep-focused users tend to dose in the morning and pair it with glycine, mirroring the Huberman approach. Almost everyone starts at the low end of a range and judges by feel, since there is no clinically validated target to aim for.

A few things jump out. The doses people discuss disagree wildly, in some cases by a factor of a hundred, which is a reminder that these are not standardized clinical protocols yet. They reflect a mix of study figures, clinic experience, and user reports.

The common rhythm is short courses, roughly 10 to 20 days, followed by a break of weeks to months, repeated a few times a year rather than taken continuously. People who use it for sleep tend to dose earlier in the day and pair it with glycine, mirroring the Huberman approach. And because it is not a stimulant, almost nobody reports an instant hit. Whatever it does seems to build and, oddly, to show up most clearly after a cycle rather than during it.

If you do run a course, start with material you can trust. Everest’s Pinealon is verified by Freedom Diagnostics and runs under $50, well below the usual $80, with code BRAINFLOW for another 10% off.

What People Stack Pinealon With

Pinealon rarely gets discussed alone. In brain-focused circles, it usually shows up inside a stack, so here is what people combine it with and why, with a clear-eyed note on the evidence.

A quick note on stacks: these combinations are built on how the compounds work and on user experience, rather than on studies that tested them together. If you want to learn what Pinealon itself does for you, running it on its own first will tell you the most.

Related reading: MOTS-c Peptide Guide  ·  BPC-157 Complete Guide  ·  Wolverine Peptide Stack

Pinealon Side Effects and Safety

The reassuring news and the asterisk arrive together here.

In the published reports, Pinealon comes across as well tolerated, with few adverse events noted. On the Koniver episode, the physician said he had not run into side effects across years of using these peptides with patients. That is a meaningful clinical impression. It is not the same as a long-term safety database, because no such database exists.

What users report anecdotally is mild: vivid dreams, the occasional light headache early on, some short-lived fatigue, and the usual redness or itch at an injection site. Nothing dramatic shows up consistently.

The theoretical unknowns deserve respect precisely because the human data is so limited. We do not know the long-term effects of repeatedly nudging gene expression. A peptide that encourages cell proliferation warrants caution in anyone with a cancer history, at least until more is known. Pregnancy and breastfeeding are a hard pass on no-data grounds. And anyone with a neurological or psychiatric condition, or on prescription medication, should treat this as a real conversation with a doctor rather than a casual add-on.

One factor is entirely in your control, and in practice it is the one that matters most: product quality. With any research peptide, purity and accurate dosing come down to the source, so tested material is worth prioritizing. Get that part right and you have handled the biggest variable there is.

Where to Get Research-Grade Pinealon

Since sourcing is the part you actually control, it is worth getting right. With Pinealon you are paying for a compound you cannot eyeball, so third-party testing and honest pricing are the whole game.

One practical note worth knowing: Pinealon is harder to find than the popular peptides, and plenty of vendors do not stock it at all. Among those that do, 10 mg often runs around $80. Everest Peptides offers the same 10 mg for under $50, third-party tested for purity by Freedom Diagnostics, with code BRAINFLOW taking another 10% off on top. Same molecule, tested, for a lot less.

Whatever you decide, the rule holds: buy from somewhere that publishes its testing. With a research peptide, a certificate of analysis is the difference between knowing what is in the vial and hoping.

Is Pinealon Legal?

Short version: widely available, not approved, and the gap between those two words matters.

In the United States, Pinealon is not FDA-approved for anything and is not a recognized dietary supplement ingredient. It is sold for research use only, which is why you will see that label on every reputable vendor. It is not a controlled substance, so it is not illegal to possess, but it cannot be legally marketed to treat or improve any condition.

In Russia, Pinealon lives inside the bioregulator and supplement ecosystem, though it is worth noting the formally approved Russian pharmaceuticals are the tissue extracts like Cortexin, not the isolated EDR molecule as a registered drug. Across the EU, UK, Canada, and especially Australia, it sits in a research or prescription gray zone, with Australia being the strictest and most aggressive at customs.

For competitive athletes, assume it is off-limits. Pinealon is not named individually on the banned list, but anti-doping rules sweep up any substance not approved for human therapeutic use under a catch-all category, which means a tested athlete should steer clear.

The takeaway is to keep four ideas separate: available, legal to possess, approved, and proven in medicine. Pinealon is the first two in most places and not the last two anywhere in the West.

Pinealon vs Semax, Selank, and the Other Brain Peptides

Pinealon does not exist in a vacuum, and knowing where it sits among its cousins helps you decide whether it is even the right tool for what you want.

If your target is focus and drive, Semax is the more obvious pick. If it is daytime calm, Selank. If it is sleep and neuron protection with a tolerance for early-stage evidence, that is Pinealon’s lane. None of these substitutes for an actual prescribed treatment if you have a diagnosed condition. They are tools for the curious, not therapies for the sick.

Related reading: Semax Peptide Guide  ·  Selank vs Semax

What Real Users Say About Pinealon

This part is anecdotal, so read it as a weather report, not a verdict. With that flag up, some patterns repeat often enough to be worth sharing.

The most common positive is sleep, especially among people over 40, echoing the Huberman story. The second most common is a delayed mental clarity, a cleaner, quicker word recall that several users say they noticed in the weeks after a cycle rather than during it. That pattern actually fits the bioregulator theory, where the peptide is supposedly setting changes in motion rather than acting like a stimulant.

The most common negative is no effect at all. Dig into those reports and they usually share a feature: a single short cycle, an unverified source, or someone expecting an obvious jolt and not getting one. The other complaints are practical, mostly cost and the hassle of an injectable.

That sourcing detail is worth keeping in mind, since a fair share of the no-effect reports likely come down to product quality. It is a good reason to start with tested Pinealon from Everest rather than the cheapest listing you can find.

Two recurring footnotes. People constantly mix Pinealon up with Epitalon in these threads, so take any secondhand claim with a grain of salt. And interest clearly spiked after Huberman talked about it, which means a chunk of the buzz is downstream of one anecdote rather than a wave of independent experiences.

My Honest Take on Pinealon

Pinealon is one of the more intriguing short peptides in the cognitive and longevity space, and I do not say that lightly.

The mechanism is genuinely novel. A peptide small enough to enter the nucleus and interact with DNA is a different idea than yet another receptor agonist, and the antioxidant and neuroprotective data behind it is real and repeatable in the lab. Layer on a careful neuroscientist tracking a doubled REM result on his own wrist, and you have a compound that earns its curiosity.

The honest counterweight is that the human evidence is thin and concentrated in one research lineage, with no independent trials confirming the headline claims. That is not a reason to write Pinealon off. It is a reason to approach it as exactly what it is: an early-stage research peptide with a promising story, best treated as a personal experiment rather than a proven protocol.

If you do explore it, do it well. Use a clean, tested source like Everest’s third-party-tested Pinealon. Run it alone first if you actually want to learn whether it does anything for you. Keep your expectations grounded and your tracking honest. Do that, and you are engaging with Pinealon the smart way, which is the only way this corner of biohacking is worth playing.

Pinealon FAQ

What is Pinealon?

Pinealon is a synthetic tripeptide, sequence Glu-Asp-Arg (EDR), from the Russian peptide bioregulator tradition. It is studied mainly for neuroprotection, brain aging, and gene expression in neurons.

Did Andrew Huberman take Pinealon?

Yes. He described using injectable Pinealon with glycine and seeing his REM sleep roughly double, tracked on a sleep device. He also said it has little human data, that he stopped taking it, and that it was his own experiment, not a recommendation.

Is Pinealon the same as Epitalon?

No. Pinealon is a tripeptide (Glu-Asp-Arg). Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly). They come from the same research group, which is why people confuse them, but they are different molecules with different research stories.

Is Pinealon FDA-approved?

No. It is not approved for any use in the United States and is sold for research purposes only. It is not a recognized dietary supplement ingredient.

Does Pinealon have human studies?

Only limited Russian observational reports, most notably a 72-patient study in people recovering from brain injury. There are no completed randomized controlled trials, and no independent group outside the original research lineage has confirmed the main human claims.

How do people use Pinealon?

Commonly in short courses of 10 to 20 days followed by a break, usually by injection or nasal spray, sometimes orally. Reported doses vary widely and are not clinically validated, so this is informational rather than a dosing recommendation.

Is Pinealon safe?

Reports so far suggest it is well tolerated, with only mild anecdotal side effects. But there is no long-term human safety data, so absence of reported problems is not the same as proven safety. Quality of the product is a major real-world factor.

Where can you buy Pinealon?

It is sold by research-peptide vendors. Most charge around $80 for 10 mg. Everest Peptides offers third-party-tested Pinealon for under $50, with an extra 10% off using code BRAINFLOW, sold for research purposes only.

This article is for educational purposes only and is not medical advice. Pinealon is not approved to diagnose, treat, cure, or prevent any disease, and is sold for research purposes only. Talk to a qualified healthcare provider before using any research peptide, especially if you are pregnant, nursing, managing a medical condition, or taking medication.

Reviewed for scientific accuracy by [Name], [Credentials].